Nick C. Davies is a Senior Consultant with 26+ years of delivering results with global pharmaceutical manufacturing leaders such as GlaxoSmithKline, and The International Partnership for Microbicides. In 2009 Nick formed NDA Consultants with a number of former GSK colleagues. NDA is an international consultancy which delivers innovative solutions globally to the pharmaceutical and biotech industries. Nicks’ expertise lies in manufacturing strategy and rationalization, strategic sourcing and outsourcing, global supply chain start-ups and leadership, new product introduction, technology transfer, and complex global change program leadership. He has established and started up new manufacturing facilities globally, rationalized global manufacturing operations, and closed and sold manufacturing facilities. He has a track record in successfully developing business cases, winning approval for multi-million dollar investment projects, turning around stock outs and supply shortages issues, and creating effective strategies to combat illegal product trade activities. He has been responsible for the annual supply of over $5billion worth of pharmaceutical product globally, and has lead new product introductions, Nick has lived in 6 different countries (UK, Thailand, South Korea, USA, Canada and Switzerland), and conducted business in more than 26 countries including China, India, Thailand, Korea, Singapore, Kenya, Brazil, and Argentina. Nick has a M.Sc. in Design of Production Systems from Loughborough University of Technology, UK, and a B.Sc. in Engineering Science from the University of Warwick, UK. He is a Fédération Européenne d’Association Nationales d’Ingénieus European Engineer, and an Engineering Council of the U.K Chartered Engineer. Nick has a Lean Sigma Green Belt, and is a Member of; the Institute of Measurement and Control, the Institute of Engineering and Technology, the International Society of Pharmaceutical Engineers, and the Project Management Institute. Nick lives in Raleigh NC USA with his wife and two children.